跳至主要内容
临床试验/NCT06076499
NCT06076499进行中(未招募)不适用

A Post-Market Observational Clinical Study to Determine the Long-Term Effectiveness and Safety of the Noctrix TOMAC (Tonic Motor Activation) System for the Treatment of Restless Legs Syndrome - The THRIVE Study

Noctrix Health, Inc.13 个研究点 分布在 1 个国家目标入组 325 人开始时间: 2023年11月15日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
325
试验地点
13
主要终点
Primary Effectiveness Endpoint

研究概览

简要总结

Multi-center post-market, observational study to assess the long-term effectiveness and safety of the NTX100 TOMAC System for patients with Restless Legs Syndrome.

详细描述

This study will assess the NTX100 TOMAC System's long-term effectiveness and safety in real-world settings. Using a prospective, observational approach, we'll monitor individuals receiving the system as part of standard care through five study visits, collecting data on clinical outcomes, device performance, and adverse events.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The subject possesses the necessary equipment, internet/phone accessibility, and communication ability to complete electronic questionnaires and respond to electronic communications and phone calls from the research staff throughout the in-home portion of the study.
  • The subject has signed a valid, IRB-approved informed consent form, can understand the requirements of the study and instructions for device usage, and can converse in English.
  • Diagnosis of restless legs syndrome.

排除标准

  • 1. The subject is unable or unwilling to comply with study requirements.

结局指标

主要结局

Primary Effectiveness Endpoint

时间窗: 1 year

Change from baseline (study entry) in IRLS total score at 1-year.

次要结局

  • CGI-I score at 1-year relative to baseline(1 year)
  • PGI-I Score at 1-Year Relative to Baseline(1 year)
  • Change from Baseline in Frequency of RLS Symptoms (Number of Days per Week) at 1-Year(1-year)
  • Change from baseline in MOS-II total score at 1-year.(1-year)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (13)

Loading locations...

相似试验